Emerging Forms of Regulated Cell Death Modalities Associated with Immunogenic Cell Death and Their Translational Potential in Cancer Immunotherapy
Tumor immunotherapy has demonstrated significant clinical value in various malignancies by activating the host antitumor immune response. However, its clinical benefits are still limited by factors such as insufficient tumor immunogenicity, an immunosuppressive tumor microenvironment (TME), and acquired drug resistance...